Jacobs Levy Equity Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$1.07M Sell
2024
Q3
$9.47M Buy
2024
Q2
$3.11M Buy
2024
Q1
$2.84M Buy
2023
Q4
$110K Buy
2023
Q3
Sell
2023
Q2
$254K Sell
2023
Q1
$1.92M Sell
2022
Q4
$2.55M Sell
2022
Q3
$2.38M Buy